Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Marine sponge leads researchers to immune system regulator

12.11.2004


A Japanese brewery, an Okinawan sea sponge and some clever detective work have enabled an international research team based at the University of Chicago to solve a biological mystery, and the solution suggests a novel way to boost the body’s defenses against cancer.



In Science Express, the online early-publication version of the journal Science, the researchers provide evidence that a sugary lipid known as iGb3 plays a key role in regulating the response of natural killer T cells, a component of the immune system that plays an important role in preventing cancer, fighting infections and perhaps triggering or avoiding autoimmune diseases.

Discovered less than ten years ago, natural killer (NK) T cells are unusual because they target lipids, often bound to carbohydrates, rather than proteins. When presented with a lipid that may signal a threat, they pump out chemical signals, such interferon-gamma and interleukin-4, which tell other components of the immune system to rid the body of these invaders.


Mice with defects in this system are prone to cancer and susceptible to infections. On the other hand, misdirected NKT cells may play a role in autoimmune diseases, such as type-1 diabetes. "Until now we had no idea what activated NKT cells except for one curious compound, a glycosphingolipid derived from a marine sponge," said study author Albert Bendelac, "but once we learned that this compound could prevent the spread of cancer in mice, a lot of people became very interested."

Bendelac, M.D., Ph.D., a professor of pathology at the University of Chicago, is one of only a handful of immunologists who concentrate on NKT cells. Scientists know a great deal about how the immune system recognizes proteins, but comparatively little about this type of cell or the mechanisms the immune system uses to sort out lipids.

NKT cells are also odd in that they fall somewhere between the brute force of innate immunity and the flexible sophistication of adaptive immunity. They appear to have an ingrained ability to recognize some bacterial lipids. At the same time, they express less-variable versions of T-cell receptors. These stripped-down receptors enable NKT cells to respond to a limited array of lipid or carbohydrate antigens when presented in certain ways.

The only substance known to fully activate NKT cells through these receptors was the glycosphingolipid derived from an Okinawan sea sponge Agelas mauritianus. In the 1990s, researchers at the Kirin Brewery in Japan found this molecule alpha-Galactosyl-ceramide, by performing a pharmaceutical screen for natural compounds with anti-tumor activity. While this compound exhibited potent anti-cancer activity in vivo, there was no clue about the mechanism of action until researchers discovered that it was recognized by NKT cells.

A purified synthetic version, known as a-GalCer or KRN 7000, is now in phase-2 human clinical trials for several tumor types. One problem with a-GalCer, however, is that it can over-stimulate NKT cells. After a burst of activity and rapid secretion of interferon-gamma, NKT cells driven by a-GalCer essentially "burn out," disappearing from the circulation for weeks. "This sponge glycolipid, a-GalCer, is not a substance seen in mammals," said Bendelac. "But it pointed us toward similar molecules in our hunt for the natural substance that activates NKT cells."

Finding the natural activator -- what immunologist call the endogenous ligand -- for these cells is crucial to understanding their biology, he added, and might provide a gentler and more enduring way to get them to fight tumors.

Bendelac’s team developed several approaches to identify the endogenous ligand. One crucial clue came from the discovery of genetically deficient mice that have almost no NKT cells. Bendelac’s team found that these mice are unable to make an enzyme required to produce iGb3. Mice that lack this enzyme have a severe NKT cell deficiency, and are cancer prone. "We don’t yet know the real function of iGb3, how it works or even how to find and measure it in the body," Bendelac said, "but we suspect is serves as an alarm of some kind. It may be produced by cells that are stressed -- damaged by an infection or transformed into cancer cells. Then it alerts the immune system to the presence of cells in trouble."

Activating NKT cells may be particularly valuable for preventing or treating cancers that spread to the liver, where NKT cells are most common.

Understanding the role of iGb3 may also provide clues about autoimmune disease. NKT cells play an important, although still poorly understood, role in regulating all sorts of immune responses. Defects in the system may allow the body to attack itself, leading to chronic inflammation or tissue damage. "It has been extremely difficult to explore the mechanisms that govern the recruitment, activation and development of NKT cells without knowledge of the natural antigens recognized by these cells," said Bendelac. "Because of their role in regulating a range of diseases, this has been a source of intense research and speculation for years."

The National Institutes of Health supported this research. Additional authors were lead author Dapeng Zhou, plus Jochen Mattner, Yuval Sagiv and Kelly Hudspeth of the University of Chicago; Carlos Cantu, Nicolas Schrantz and Luc Teyton of the Scripps Research Institute; Ning Yin, Ying Gao and Paul Savage of Brigham Young University; Yunping Wu, Tadashi Yamashita and Richard Proia of the NIH; Susan Teneberg of Goteborg University, Sweden; Dacheng Wang of the Chinese Academy of Sciences; and Steven Levery of the University of New Hampshire.

John Easton | EurekAlert!
Further information:
http://www.uchospitals.edu

More articles from Life Sciences:

nachricht Designed proteins to treat muscular dystrophy
29.06.2017 | Universität Basel

nachricht Funding of Collaborative Research Center developing nanomaterials for cancer immunotherapy extended
28.06.2017 | Johannes Gutenberg-Universität Mainz

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

High conductive foils enabling large area lighting

29.06.2017 | Power and Electrical Engineering

Designed proteins to treat muscular dystrophy

29.06.2017 | Life Sciences

Climate Fluctuations & Non-equilibrium Statistical Mechanics: An Interdisciplinary Dialog

29.06.2017 | Seminars Workshops

VideoLinks
B2B-VideoLinks
More VideoLinks >>>